In a previous piece covering semaglutide and other GLP-1 medication, we discussed some of the ways that employers are adapting in order to offer these drug treatments to employees without exposing the health plan to out-of-control costs, including implementing lifetime caps, minimum BMI caps, and limiting access to cheaper GLP-1 options: Lifetime Cap : Some employers are limiting their exposure to excessive GLP-1 weight loss expenses by setting a lifetime cap on the amount of funds available to covered employees
Clinical studies also show promising results, suggesting that GLP1RA could be a valuable addition to the current array of drugs available for Parkinsons disease treatment 20
In vivo , the GIP(5-31) analogue inhibited GIP-stimulated insulin secretion in human islets
Furthermore, colon cancer patients who engaged in an exercise routine had a 40% reduction in cancer recurrence and a 63% reduction in mortality
The half-life is too long
Due to a combination of host and microbial factors, NTHi persists in the lower airways of these individuals which is associated with an increased frequency of exacerbations, worsening symptoms, inflammation causing tissue damage, compositional changes to the lung microbiome and overall worse clinical prognosis (Sethi and Murphy, 2001
